Global pharma giants ramp up investments in China’s biotech sector #coolchina #CGTN
Global pharma giants ramp up investments in China’s biotech sector #coolchina
Following China’s Two Sessions, executives from world-leading pharmaceutical companies visited Beijing to explore new opportunities. For the first time, biomedicine has been designated as an emerging pillar industry, as China accelerates efforts to build a “Healthy China” by 2035.
Major investments, including Eli Lilly’s $3 billion plan and AstraZeneca’s about$14 billion commitment, underscore the strong appeal of the Chinese market for global drugmakers. #coolchina
📺 Subscribe to our YouTube channel and stay updated with our latest analysis and interviews:👇
https://www.youtube.com/channel/UCgrNz-aDmcr2uuto8_DL2jg 👈
Download our APP on Apple Store (iOS): https://ift.tt/BW9J5GH
Download our APP on Google Play (Android): https://ift.tt/7DzXuiW
For more:
https://ift.tt/BOTYQfv
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
コメントを送信